Zevra Therapeutics, Inc. - Common Stock (NQ:ZVRA)

10.26 UNCHANGED

Delayed Quote Updated: 4:00 PM EST, Nov 3, 2026 Add to My Watchlist

Price and Volume

Volume	0
Open	10.26
Bid (Size)	9.800 (100)
Ask (Size)	10.70 (100)
Prev. Close	10.26
Today's Range	10.26 - 10.26
52wk Range	8.010 - 15.04
Shares Outstanding	33,932,639
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

Zevra Therapeutics Q3 Earnings Call Highlights ↗

November 03, 2026

Zevra Therapeutics (NASDAQ:ZVRA) reported third-quarter 2026 net revenue of $37.8 million, up 45% from $26.1 million a year earlier, driven primarily by U.S. sales of MIPLYFFA for Niemann-Pick disease...

Via MarketBeat

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Zevra Therapeutics, Inc. - ZVRA

August 11, 2026

From Pomerantz LLP

Via GlobeNewswire

Performance

52-Week Range 31.8% below 52-week high

10.26

8.0152W Low 15.0452W High

1 Week 2.7% below 1-week high

9.821W Low 10.551W High

Zevra Therapeutics, Inc. - Common Stock (ZVRA) traded between $8.01 and $15.04 over the past 52 weeks and last traded at $10.26, 31.8% below its 52-week high. Over the past week it ranged between $9.82 and $10.55.

Past 12 Months

-0.5%

-4.1%

-2.5%

-3.3%

+23.0%

+0.5%

1W -$0.05

1M -$0.44

3M -$0.26

6M -$0.35

YTD +$1.92

1Y +$0.05

ZVRA was +0.5% over the past year, -3.3% over six months, +23.0% year to date, -0.5% in the last week.

12 Months vs Market

ZVRA

+0.5%

DIA

+9.2%

SPY

+10.4%

QQQ

+8.4%

IWM

+14.0%

Over the past 12 months ZVRA returned +0.5% versus DIA (Dow) +9.2%, SPY (S&P 500) +10.4%, QQQ (Nasdaq 100) +8.4% and IWM (Russell 2000) +14.0%.

Volume & Liquidity

690.2K

753.9K

882.8K

1.4M

YTD

1.2M

ZVRA's 3-month average daily volume is 882.8K.

More News

Zevra Therapeutics Q2 Earnings Call Highlights ↗

August 06, 2026

Via MarketBeat

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Zevra Therapeutics, Inc. - ZVRA

August 04, 2026

From Pomerantz LLP

Via GlobeNewswire

Zevra Therapeutics (NASDAQ:ZVRA) Shares Surge After Blowout Q1 Earnings Beat ↗

May 06, 2026

Via Chartmill

Zevra Therapeutics Inc (NASDAQ:ZVRA) Stock Surges 21% After Blowing Past Q4 Earnings Estimates ↗

March 09, 2026

Via Chartmill

Earnings Scheduled For November 5, 2025 ↗

November 05, 2025

Via Benzinga

ZVRA Investor Alert: Levi & Korsinsky Notifies Investors of Investigation Into Zevra Therapeutics (ZVRA)

July 29, 2026

From Levi & Korsinsky, LLP

Via Business Wire

ZVRA Investors Have Opportunity to Join Zevra Therapeutics, Inc. Fraud Investigation with SBS Law

July 27, 2026

From Schall, Brown & Schwartz LLP

Via Business Wire

These stocks are gapping in today's session ↗

July 24, 2026

Via Chartmill

These stocks are moving in today's pre-market session ↗

July 24, 2026

Via Chartmill

Zevra (ZVRA) Q1 2026 Earnings Call Transcript ↗

May 06, 2026

Via The Motley Fool

Why Zevra Therapeutics Stock Zoomed 21% Higher Today ↗

March 10, 2026

Via The Motley Fool

Gapping stocks in Tuesday's session ↗

March 10, 2026

Via Chartmill

Stay updated with the stocks that are on the move in today's pre-market session. ↗

March 10, 2026

Via Chartmill

Nasdaq, S&P 500 Futures Turn Green On Iran War De-Escalation Signals: Why NVDA, ORCL, JOBY, VRTX, ZVRA Are On Traders' Radar Today ↗

March 10, 2026

Via Stocktwits

Dow, S&P 500, Nasdaq Futures Dip After Wall Street Rebound: Why SLS, ZVRA, RLMD, USO, CASY Are Trending After-Hours ↗

March 09, 2026

Via Stocktwits

ZVRA Stock Soars On Upbeat Q4 Results, Optimism For EMA Approval Of Niemann-Pick Disease Treatment ↗

March 09, 2026

Via Stocktwits

Top movers in Monday's after hours session ↗

March 09, 2026

Via Chartmill

Zevra Therapeutics Shareholders Are Encouraged to Reach Out to Johnson Fistel for More Information About Potentially Recovering Their Losses

February 18, 2026

From Johnson Fistel, PLLP

Via Business Wire

This Biotech Is Up 194% in a Year but One Investor Took Millions Off the Table ↗

December 28, 2025

Via The Motley Fool

ANI Stock Is Up 49% This Past Year, Revenue Is Surging, and One Fund Still Walked Away ↗

December 28, 2025

Via The Motley Fool

Zevra (ZVRA) Q3 2025 Earnings Call Transcript ↗

November 06, 2025

Via The Motley Fool

Zevra Therapeutics' Stock Soars on Strong Performance and Strategic Wins: What It Means for Investors

October 06, 2025

Via MarketMinute

Top Stocks With Earnings This Week: Joby, IonQ, AMD and More ↗

November 03, 2025

Via Benzinga

Frequently Asked Questions

Is Zevra Therapeutics, Inc. - Common Stock publicly traded?

Yes, Zevra Therapeutics, Inc. - Common Stock is publicly traded.

What exchange does Zevra Therapeutics, Inc. - Common Stock trade on?

Zevra Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market

What is the ticker symbol for Zevra Therapeutics, Inc. - Common Stock?

The ticker symbol for Zevra Therapeutics, Inc. - Common Stock is ZVRA on the Nasdaq Stock Market

What is the current price of Zevra Therapeutics, Inc. - Common Stock?

The current price of Zevra Therapeutics, Inc. - Common Stock is 10.26

When was Zevra Therapeutics, Inc. - Common Stock last traded?

The last trade of Zevra Therapeutics, Inc. - Common Stock was at 11/03/26 04:00 PM ET

What is the market capitalization of Zevra Therapeutics, Inc. - Common Stock?

The market capitalization of Zevra Therapeutics, Inc. - Common Stock is 348.15M

How many shares of Zevra Therapeutics, Inc. - Common Stock are outstanding?

Zevra Therapeutics, Inc. - Common Stock has 348M shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.